Medical News

RSS

Study: Expedited medical device reviews account for majority of recalls

The analysis, which was published in the Archives of Internal Medicine, connected the Food and Drug Administration's most urgent medical device recalls with high-risk devices that were subject to "speedy" review.

16 Feb 2011

Halozyme-Roche announce initiation of Phase 3 subcutaneous MabThera trial in follicular NHL

Halozyme Therapeutics, Inc. and Roche today announced the first patient received subcutaneous MabThera (rituximab), an anticancer biologic, in a Phase 3 registration trial using Enhanze technology.

16 Feb 2011

Viral Genetics' lead researcher, Advisor to receive Lauren F. Brooks Hope Award

Viral Genetics, Inc. announced today that lead researcher Dr. M. Karen Newell Rogers and Advisor Mr. Richard Gerstner will receive the Lauren F. Brooks Hope Award, presented by Time for Lyme, Inc.

16 Feb 2011

Sanofi-aventis, Sunnybrook enter agreement to develop and commercialize vasculotide

Sanofi-aventis and Sunnybrook Health Sciences Centre announced that they have entered into a research agreement and licensing option for vasculotide, an investigational compound to treat chronic wounds. This includes neuropathic diabetic foot ulcers caused by a lack of sensation and neuropathic ulcers that are complicated by peripheral arterial disease, commonly called neuroischemic diabetic foot ulcers.

16 Feb 2011

AHF condemns budget move by House Republicans for global AIDS programs

AIDS Healthcare Foundation, which provides AIDS medical care and services to more than 152,000 individuals in 26 countries worldwide, today strongly condemned a move by House Republicans, who on Friday proposed slashing President Obama's 2011 funding for global AIDS programs by $813 million.

16 Feb 2011

Medicare pay cut for docs already drawing fire

Critics said the method used in the budget blueprint would cause serious problems. But some news reports indicate the inclusion of this Medicare "doc fix" would help build support within the physician community for the president's health care agenda.

16 Feb 2011

Study: RAPI tool more effective at predicting future alcohol dependence of teen-age drinkers

A widely used index for assessing adolescent drinking-related problems has been found to be effective at predicting the future alcohol dependence of teen-age drinkers, according to an Indiana University study which also found that the association was stronger for adolescent female drinkers.

16 Feb 2011

Fibrocell Science sells $7.8 million Series D convertible preferred stock

Fibrocell Science, Inc., a biotechnology company focused on the development of autologous cell therapies for aesthetic, medical and scientific applications, announced today that between December 8, 2010 and February 9, 2011 it entered into agreements with certain accredited investors, pursuant to which the Company sold to the purchasers in the aggregate approximately $7.8 million of the Company's Series D convertible preferred stock, which is convertible into shares of common stock at a conversion price of $0.50 per share.

16 Feb 2011

Genetic proof for anti-cancer properties of antioxidants and autophagy inhibitors

Researchers from Jefferson's Kimmel Cancer Center have genetic evidence suggesting the antioxidant drugs currently used to treat lung disease, malaria and even the common cold can also help prevent and treat cancers because they fight against mitochondrial oxidative stress-a culprit in driving tumor growth.

16 Feb 2011

New report examines impact of Affordable Care Act on national immunization policy

A new report issued by the George Washington University School of Public Health and Health Services and funded by the U.S. Department of Health and Human Services analyzes the impact of Affordable Care Act on national immunization policy. The report examines a wide range of reforms that are aimed at strengthening immunization policy and practice.

16 Feb 2011

CR still under consideration as House GOP vehicle to defund health law

House Speaker John Boehner, R-Ohio, said this plan is still under discussion. Meanwhile, as the House considers this Continuing Resolution, which would provide current year funding for the federal government, it will do so under new rules for debate.

16 Feb 2011

Thermo Fisher Scientific extends tender offer for Dionex

Thermo Fisher Scientific Inc., the world leader in serving science, today announced that its previously announced tender offer to acquire all of the outstanding shares of Dionex Corporation for $118.50 per share in cash has been extended and will now expire at 12:00 midnight, New York City time, at the end of Thursday, April 7, 2011, unless further extended.

From Thermo Fisher Scientific Inc. 16 Feb 2011

Study finds worse outcomes in workers undergoing spinal fusion surgery

For workers' compensation patients with chronic low back pain, spinal fusion surgery leads to worse long-term outcomes—including a lower rate of return to work—compared to nonsurgical treatment, suggests a study in the February 15th issue of Spine. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

16 Feb 2011

Research: Plants may assist in detecting environmental contaminants, explosives

Someday, that potted palm in your living room might go from green to white, alerting you to a variety of nasty contaminants in the air, perhaps even explosives.

16 Feb 2011

New study confirms effectiveness of inhaled epinephrine to treat croup

For more than 30 years, pediatricians have treated children who have croup with inhaled epinephrine to relieve their symptoms quickly. Now, a new review confirms the value of this approach to treat this common respiratory illness, which sometimes turns serious and - in rare instances - can prove fatal.

16 Feb 2011

NGDI-UBC, CDRD partner for drug development platform to treat neglected global diseases

The Centre for Drug Research and Development and the Neglected Global Diseases Initiative at the University of British Columbia today announced that they will collaborate on developing interventions for neglected global diseases and ensuring their delivery to those in need.

16 Feb 2011

Orabrush closes $2.5 million investment round

Orabrush, the tongue cleaner that helps cure bad breath, today announced that the company has closed a $2.5 million investment round with True Ventures of Palo Alto and returning investor 2x Consumer Products Growth Partners of Chicago. Funds will be used to help further accelerate the company's retail growth by maximizing its exceptional online brand and expanding its retail partnerships and distribution channels throughout the world.

16 Feb 2011

Obama's 2012 budget proposal requests boost for GHI funding, slight core budget increases for State, USAID

President Barack Obama "released his budget proposal for fiscal year 2012 on Monday," the New York Times reports. The president's "fiscal 2012 budget allocates $47 billion for the State Department and the U.S. Agency for International Development, which reflects only a 1 percent increase over 2010 levels for the core budget," National Journal writes.

16 Feb 2011

Obama budget draws GOP criticism for not taking on entitlements

Although reports indicate President Barack Obama's proposed budget would reduce the deficit by more than $1 trillion over 10 years, it did not offer major changes to Medicare, Medicaid or Social Security — which total about 40 percent of federal spending.

16 Feb 2011

BCVI offers multidisciplinary approach to treat patients with atrial fibrillation

More than 2.6 million Americans suffer from atrial fibrillation —an erratic heartbeat. If left untreated, the condition can lead to stroke or heart failure. For three decades, 58 year old David Ryan was one of the millions of Americans suffering from the disease.

16 Feb 2011

Medical News

Study: Expedited medical device reviews account for majority of recalls

Halozyme-Roche announce initiation of Phase 3 subcutaneous MabThera trial in follicular NHL

Viral Genetics' lead researcher, Advisor to receive Lauren F. Brooks Hope Award

Sanofi-aventis, Sunnybrook enter agreement to develop and commercialize vasculotide

AHF condemns budget move by House Republicans for global AIDS programs

Medicare pay cut for docs already drawing fire

Study: RAPI tool more effective at predicting future alcohol dependence of teen-age drinkers

Fibrocell Science sells $7.8 million Series D convertible preferred stock

Genetic proof for anti-cancer properties of antioxidants and autophagy inhibitors

New report examines impact of Affordable Care Act on national immunization policy

CR still under consideration as House GOP vehicle to defund health law

Thermo Fisher Scientific extends tender offer for Dionex

Study finds worse outcomes in workers undergoing spinal fusion surgery

Research: Plants may assist in detecting environmental contaminants, explosives

New study confirms effectiveness of inhaled epinephrine to treat croup

NGDI-UBC, CDRD partner for drug development platform to treat neglected global diseases

Orabrush closes $2.5 million investment round

Obama's 2012 budget proposal requests boost for GHI funding, slight core budget increases for State, USAID

Obama budget draws GOP criticism for not taking on entitlements

BCVI offers multidisciplinary approach to treat patients with atrial fibrillation

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News